Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how the £86 million to support innovators and the NHS in overcoming barriers to getting new, innovative technologies to patients as part of the Accelerated Access Review will be allocated.

£86 million has been allocated by the Department for Business, Energy and Industrial Strategy and the Department of Health and Social Care as follows:

- £39 million to improve local adoption and uptake of innovative medical technologies through the 15 Academic Health Science Networks, who will be given increased capacity to help innovative products find the right support and to promote regional adoption and spread;

- £35 million over four years to encourage and support innovators to develop more world-leading digital solutions. Through the Digital Health Technology Catalyst, small and medium-sized enterprises (SME)-led projects will be supported to develop the evidence base required to launch their products in the National Health Service;

- £6 million to help the NHS to adopt and integrate new technologies into everyday practice, through the Pathway Transformation Fund; and

- £6 million over three years from the Industrial Strategy Challenge Fund to support SMEs to address the difficulties they face in getting their new medicines and medical technologies adopted in the market by supporting them to gather the evidence required to prove clinical efficacy.